Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Inventory (2020 - 2025)

Historic Inventory for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $1.7 million.

  • Neuroone Medical Technologies' Inventory fell 1370.96% to $1.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 million, marking a year-over-year decrease of 1370.96%. This contributed to the annual value of $2.2 million for FY2025, which is 1549.62% down from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Inventory of $1.7 million as of Q4 2025, which was down 1370.96% from $2.2 million recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Inventory registered a high of $2.6 million during Q3 2024, and its lowest value of $52182.0 during Q2 2021.
  • Moreover, its 5-year median value for Inventory was $1.5 million (2023), whereas its average is $1.3 million.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Inventory skyrocketed by 155833.09% in 2021, and later tumbled by 1549.62% in 2025.
  • Quarter analysis of 5 years shows Neuroone Medical Technologies' Inventory stood at $229115.0 in 2021, then surged by 294.37% to $903554.0 in 2022, then soared by 78.04% to $1.6 million in 2023, then increased by 20.03% to $1.9 million in 2024, then fell by 13.71% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q4 2025, $2.2 million for Q3 2025, and $1.9 million during Q2 2025.